HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical utility of endocrine markers predicting myocardial siderosis in transfusion dependent thalassemia major.

AbstractBACKGROUND:
Endocrinopathy due to iron overload is the most common morbidity whereas myocardial siderosis causing toxic cardiomyopathy is the leading cause of mortality among patients with transfusion dependent thalassemia major (TDTM). If detected early, this can be treated with aggressive chelation. T2* cardiac magnetic resonance imaging (CMR) guided chelation protocols are now the gold standard but have limited availability in low and middle-income countries. We hypothesized that markers of endocrine dysfunction would correlate with T2* CMR and can be used to predict the severity of myocardial siderosis and guide chelation therapy.
METHODOLOGY:
We undertook a multicenter retrospective study of 280 patients with TDTM to assess the prevalence of endocrinopathies and the predictive value of a number of individual and composite markers of endocrinopathy with T2* CMR.
RESULTS:
The prevalence of hypogonadism, stunting, hypoparathyroidism, and hypothyroidism was 82%, 69%, 40%, and 30%, respectively. The sensitivity of hypogonadism and stunting predicting severe myocardial siderosis was 90% and 80%, respectively.
CONCLUSION:
We conclude that clinical markers of endocrine dysfunction, especially hypogonadism (positive likelihood ratio [LR+] = 1.4, 95% confidence interval [CI] = 1.0-1.9; positive predictive value [PPV] = 77%, 95% CI = 70-82; negative predictive value [NPV] = 57%, 95% CI = 34-77] and stunting (LR+ = 1.3, 95% CI = 1.1-1.6; PPV = 64%, 95% CI = 60-69; NPV = 55%, 95% CI = 45-64) in TDTM can predict severe myocardial siderosis and can potentially guide chelation therapy, especially where access to T2* CMR is limited.
AuthorsLubaina Ehsan, Mariam Rashid, Najveen Alvi, Khadija Awais, Omair Nadeem, Aleezay Asghar, Fatimah Sajjad, Malika Fatima, Asim Qidwai, Shabneez Hussain, Erum Hasan, Nick Brown, Sadaf Altaf, Babar Hasan, Salman Kirmani
JournalPediatric blood & cancer (Pediatr Blood Cancer) Vol. 65 Issue 10 Pg. e27285 (10 2018) ISSN: 1545-5017 [Electronic] United States
PMID29893484 (Publication Type: Journal Article, Multicenter Study)
Copyright© 2018 Wiley Periodicals, Inc.
Chemical References
  • Biomarkers
Topics
  • Adolescent
  • Biomarkers
  • Blood Transfusion
  • Cardiomyopathies (diagnosis, etiology)
  • Child
  • Female
  • Growth Disorders (etiology)
  • Humans
  • Hypogonadism (etiology)
  • Hypoparathyroidism (etiology)
  • Hypothyroidism (etiology)
  • Iron Overload (complications, diagnosis)
  • Male
  • Retrospective Studies
  • Sensitivity and Specificity
  • beta-Thalassemia (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: